NON-SMALL CELL A171901

Study #A171901

Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist’s / Patient’s Choice)

Back To Clinical Trials